US20120065672A1 - Adhesive Laminates for Rapid Wound Occlusion - Google Patents

Adhesive Laminates for Rapid Wound Occlusion Download PDF

Info

Publication number
US20120065672A1
US20120065672A1 US13/300,177 US201113300177A US2012065672A1 US 20120065672 A1 US20120065672 A1 US 20120065672A1 US 201113300177 A US201113300177 A US 201113300177A US 2012065672 A1 US2012065672 A1 US 2012065672A1
Authority
US
United States
Prior art keywords
adhesive
layer
dispenser
agent
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/300,177
Inventor
Stephen T. Flock
Kevin S. Marchitto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rocky Mountain Biosystems Inc
Original Assignee
Flock Stephen T
Marchitto Kevin S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US53491704P priority Critical
Priority to US11/032,427 priority patent/US7758939B2/en
Priority to US12/804,292 priority patent/US8053052B2/en
Priority to US13/291,619 priority patent/US8343606B2/en
Application filed by Flock Stephen T, Marchitto Kevin S filed Critical Flock Stephen T
Priority to US13/300,177 priority patent/US20120065672A1/en
Publication of US20120065672A1 publication Critical patent/US20120065672A1/en
Assigned to ROCKY MOUNTAIN BIOSYSTEMS, INC reassignment ROCKY MOUNTAIN BIOSYSTEMS, INC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: FLOCK, STEPHEN, MARCHITTO, KEVIN
Application status is Abandoned legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/08Wound clamps or clips, i.e. not or only partly penetrating the tissue ; Devices for bringing together the edges of a wound
    • A61B17/085Wound clamps or clips, i.e. not or only partly penetrating the tissue ; Devices for bringing together the edges of a wound with adhesive layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/10Surgical instruments, devices or methods, e.g. tourniquets for applying or removing wound clamps, e.g. containing only one clamp or staple; Wound clamp magazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/02Adhesive plasters or dressings
    • A61F13/023Adhesive plasters or dressings wound covering film layers without a fluid handling layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F15/00Auxiliary appliances for wound dressings; Dispensing containers for dressings or bandages
    • A61F15/001Packages or dispensers for bandages, cotton balls, drapes, dressings, gauze, gowns, sheets, sponges, swabsticks or towels
    • A61F15/002Packages or dispensers for bandages, cotton balls, drapes, dressings, gauze, gowns, sheets, sponges, swabsticks or towels dispensers for web or tape like bandages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/10Surgical instruments, devices or methods, e.g. tourniquets for applying or removing wound clamps, e.g. containing only one clamp or staple; Wound clamp magazines
    • A61B17/105Wound clamp magazines
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T156/00Adhesive bonding and miscellaneous chemical manufacture
    • Y10T156/12Surface bonding means and/or assembly means with cutting, punching, piercing, severing or tearing
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/14Layer or component removable to expose adhesive
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/14Layer or component removable to expose adhesive
    • Y10T428/1405Capsule or particulate matter containing [e.g., sphere, flake, microballoon, etc.]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/14Layer or component removable to expose adhesive
    • Y10T428/1419Wax containing
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/14Layer or component removable to expose adhesive
    • Y10T428/1424Halogen containing compound
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/14Layer or component removable to expose adhesive
    • Y10T428/1424Halogen containing compound
    • Y10T428/1429Fluorine
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/14Layer or component removable to expose adhesive
    • Y10T428/1471Protective layer
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/24Structurally defined web or sheet [e.g., overall dimension, etc.]
    • Y10T428/24273Structurally defined web or sheet [e.g., overall dimension, etc.] including aperture
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/28Web or sheet containing structurally defined element or component and having an adhesive outermost layer
    • Y10T428/2852Adhesive compositions
    • Y10T428/2878Adhesive compositions including addition polymer from unsaturated monomer
    • Y10T428/2887Adhesive compositions including addition polymer from unsaturated monomer including nitrogen containing polymer [e.g., polyacrylonitrile, polymethacrylonitrile, etc.]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/31504Composite [nonstructural laminate]
    • Y10T428/31855Of addition polymer from unsaturated monomers
    • Y10T428/31935Ester, halide or nitrile of addition polymer

Abstract

Provided herein are protective laminate devices comprising a biocompatible non-adherent substance and a fast-setting adhesive and methods of use. Also provided is a dispenser for an adhesive tape. The protective laminate devices and methods may be used for wound closure.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This divisional application claims benefit of priority under 35 U.S.C. §120 of pending divisional application U.S. Ser. No. 13/291,619, filed Nov. 8, 2011, which claims benefit of priority under 35 U.S.C. §120 of continuation application U.S. Ser. No. 12/804,292, filed Jul. 19, 2010, now U.S. Pat. No. 8,053,052, which claims benefit of priority under 35 U.S.C. §120 of non-provisional application U.S. Ser. No. 11/032,427, filed Jan. 10, 2005, now U.S. Pat. No. 7,758,939, which claims benefit of priority under 35 U.S.C. §119(e) of provisional application U.S. Ser. No. 60/534,917, filed Jan. 8, 2004, now abandoned, then entirety of all of which are hereby incorporated by reference.
  • BACKGROUND OF THE INVENTION
  • 1. Field of the Invention
  • The present invention relates generally to the fields of biomedical engineering, biochemistry and surgical procedures. More specifically, the present invention provides a device and methods using wound laminates and occlusive coatings suitable for sealing tissues or enhancing wound healing.
  • 2. Description of the Related Art
  • Conventional methods of wound closure following surgery consist of applying sutures or staples to join two or more tissues that have been dissected. Various alternative methods have been developed to fasten tissues together without the use of a conventional staple or suture. Commercial electrosurgery and electrocautery devices, which employ heat, are often used for sealing external and internal wounds. Other ways for sealing vessels using other forms of electromagnetic energy, such as that produced by lasers, are known.
  • Tissue adhesives consisting of biomolecules, such as fibrin, currently are used to “glue” tissue-to-tissue. The results are often sub-optimal due to weak adherence and dissolution of the fibrin clot. Cyanoacrylates of various types, derived from instant bonding glues, e.g., SUPERGLUE™, also are used on tissue and available for use in the home, although currently they are approved only in the United States for external use. DERMABOND™, an approved topical skin adhesive, is 2-octyl cyanoacrylate with added colorant D&C Violet #2 for easy visualization. The package insert for this material warns that any inadvertent contact with any body tissue and any surfaces or equipment, such as latex gloves or stainless steel, should be avoided. The adhesive is applied by apposing the tissue edges with fingers or forceps and applying the liquid adhesive in several stroking motions not unlike that used with a paintbrush, allowing time to dry in between strokes.
  • Practically, there is a significant problem with the use of fast-setting skin adhesives. Bonding may result in unintentional bonding of human or inanimate applicators. During application of cyanoacrylate-based adhesives the care provider often glues his or her examination gloves to the patients. Unintentional bonding requires the bonded materials to be peeled apart potentially causing local trauma. Acetone is a solvent of cyanoacrylate that can help loosen the bond, but the use of acetone on an open wound can be problematic. Furthermore, DERMABOND™ is not indicated for use in high-tension skin areas, where it's holding force may be insufficient to maintain wound closure, or near the eyes where runoff of the glue may result in unintentional adhesion.
  • The inventors have recognized a need in the art for an improvement in the devices and methods used for joining tissues separated through surgery or through trauma. The prior art is deficient in the lack of fast-setting adhesives and the use thereof in minimizing the risk of unintentional bonding during use of these fast-setting adhesives. The present invention fulfills this longstanding need and desire in the art.
  • SUMMARY OF THE INVENTION
  • The present invention is directed to a laminate device for protecting an adhesive during manipulation thereof. The laminate device comprises an adhesive and at least one layer of a biocompatible non-adherent substance disposed in protective relationship to the adhesive. The present invention is directed to a device further comprising at least one removable layer disposed in contact with the adhesive, with one or more layers of the biocompatible non-adherent substance or a combination thereof. The present invention also is directed further to a device comprising an emulsifying agent, a solubilizing agent, a wetting agent, a taste modifying agent, a plasticizer, a bioactive agent, a water soluble inert filler, a preservative, a buffering agent, a coloring agent, a stabilizer, or a combination thereof and/or a pharmaceutical in one or more biocompatible non-adherent layers.
  • The present invention also is directed to a method of preventing unintentional bonding of an adhesive during application thereof to one or more tissues. The laminate device described herein is positioned on the tissue(s) such that the adhesive layer comprising the laminate device is in contact with the tissue(s) and activating the adhesive. The removal of the removable layer(s) comprising the laminate device is dependent upon the disposition of the removable layer within the laminate device. If the removable layer is disposed only on a surface of the adhesive layer, the removable layer is removed prior to positioning the laminate device. If the removable layer(s) is disposed on one or more layers of the biocompatible non-adherent substance comprising the laminate device, the removable layer(s) is removed after activating the adhesive or a combination thereof. The biocompatible non-adherent substance and the removable layer(s) protect the adhesive layer during application thereof thereby preventing unintentional bonding of the adhesive. The method further may comprise setting the adhesive to join the tissues.
  • The present invention is directed further to a method of delivering a bioactive agent to one or more tissues. The laminate device described herein is positioned upon the tissue(s) where one or more of the layers of the laminate device comprises the bioactive agent thereby delivering the bioactive agent to the tissue(s). The present invention is directed further to a related method where the bioactive agent is the adhesive comprising the layer in contact with the tissue(s) whereby setting the adhesive joins the tissue(s). The present invention is directed further to another related method where the bioactive agent is a pharmaceutical comprising one or more of the layers of the laminate device described herein disposed in protective relationship with a porous or permeable adhesive layer in contact with the tissue(s) whereby the pharmaceutical diffuses therefrom through the porous or permeable adhesive layer.
  • The present invention is directed further still to a dispenser for an adhesive tape. The dispenser comprises a biocompatible non-adherent substance, a means to dispense an adhesive layer onto a layer of the biocompatible non-adherent substance, a means to cut the combined layers, and a housing having an opening.
  • The present invention is directed further still to a method of forming an adhesive tape to join one or more tissues. A length of the layer of the biocompatible non-adherent substance is withdrawn through the opening in the dispensor described immediately supra while simultaneously dispensing the adhesive layer along the length of the layer of the biocompatible non-adherent substance via the brush in the dispensor. The combined layers are cut via the cutting means comprising the dispenser after sufficient length has been withdrawn thereby forming the adhesive tape. Additionally, the method provides for positioning the adhesive tape on one or more tissues such that the adhesive layer is in contact with the tissue(s) and setting the adhesive thereby joining the tissue(s).
  • Other and further aspects, features, and advantages of the present invention will be apparent from the following description of the presently preferred embodiments of the invention given for the purpose of disclosure.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • So that the matter in which the above-recited features, advantages and objects of the invention, as well as others that will become clear, are attained and can be understood in detail, more particular descriptions of the invention briefly summarized above may be had by reference to certain embodiments thereof that are illustrated in the appended drawings. These drawings form a part of the specification. It is to be noted, however, that the appended drawings illustrate preferred embodiments of the invention and therefore are not to be considered limiting in their scope.
  • FIGS. 1A-1C depict an adherent tissue patch without a non-stick removable layer (FIG. 1A) and with a non-stick removable layer (FIGS. 1B-1C).
  • FIG. 2 depicts an adherent tissue patch positioned over a laceration on the dorsal aspect of a hand.
  • FIGS. 3A-3B depict an adhesive patch comprising a reservoir containing a bioactive material incorporated within the patch and a porous adhesive layer (FIG. 3A) or a permeable adhesive layer (FIG. 3B).
  • FIG. 4 depicts an adherent tissue patch dispenser.
  • DETAILED DESCRIPTION OF THE INVENTION
  • In one embodiment of the present there is provided a laminate device for protecting an adhesive during manipulation thereof, comprising the adhesive; and at least one layer of a biocompatible non-adherent substance disposed in protective relationship to the adhesive. In this embodiment the laminate device may comprise a patch.
  • Further to this embodiment the laminate device may comprise at least one removable layer disposed in contact with the adhesive, with one or more layers of the biocompatible non-adherent substance or a combination thereof. In one aspect of this embodiment the removable layer is disposed in contact with the adhesive and is removable prior to manipulation of the adhesive. In another aspect the removable layer is disposed between the adhesive and the biocompatible non-adherent substance and is removable after manipulation of the adhesive. In yet another aspect the removable layer is disposed in a covering relationship to an outer layer of the biocompatible non-adherent substance and is removable after manipulation of the adhesive. The removable layer may comprise teflon or a cellulose impregnated with a lipid. Examples of the lipid are lecithin, polyethylene glycol or a wax.
  • In all aspects of this embodiment the biocompatible non-adherent substance dissolves upon contact with a fluid, e.g., water. The biocompatible non-adherent substance may be a hydrocolloid such as pullulan. Additionally, in all aspects of this embodiment the adhesive may comprise a cyanoacrylate or a derivative thereof, a protein or a synthetic polymer. Furthermore the adhesive may be porous or permeable.
  • In one aspect of this embodiment the biocompatible non-adherent substance may be disposed on a surface of the adhesive. In another aspect one or more layer(s) of the biocompatible non-adherent substance may comprise the adhesive incorporated therein. In a related aspect the adhesive may be contained within a rupturable reservoir within one of the layer(s).
  • In related aspects one or more layers of the biocompatible non-adherent substance further may comprise an emulsifying agent, a solubilizing agent, a wetting agent, a taste modifying agent, a plasticizer, an active agent, a water soluble inert filler, a preservative, a buffering agent, a coloring agent, an aesthetic design, a stabilizer, or a combination thereof. In another related aspect one or more layers of the biocompatible non-adherent substance further comprises a pharmaceutical. In yet another related aspect the pharmacutical may be contained within a rupturable reservoir within the layer(s).
  • In another embodiment of the present invention, there is provided a method of preventing unintentional bonding of an adhesive during application thereof to one or more tissues, comprising positioning the laminate device described herein onto the tissue(s) where the adhesive layer comprising the laminate device is in contact with the tissue(s); activating the adhesive; and removing the removable layer(s) comprising the laminate device, where, if the removable layer is disposed only on a surface of the adhesive layer, then removable layer is removed prior to positioning said laminate device or if the removable layer(s) is disposed on one or more layers of the biocompatible non-adherent substance comprising the laminate device, then the removable layer(s) is removed after activating the adhesive or a combination thereof; wherein the biocompatible non-adherent substance and the removable layer(s) protect the adhesive layer during application thereof thereby preventing unintentional bonding of the adhesive.
  • Further to this embodiment the method comprises setting the adhesive to join the tissue(s). In this embodiment the layers of the biocompatible non-adherent substance and the additional agents added thereto, the adhesive layer, the removable layers and the disposition of the layers within the laminate device are as described supra. Additionally, the biocompatible non-adherent substances and the adhesives are as described supra.
  • In yet another embodiment of the present invention, there is provided a method of delivering a bioactive agent to one or more tissues, comprising positioning the laminate device described herein in contact with said tissue(s) wherein one or more of the layers of the laminate device comprises said bioactive agent thereby delivering said bioactive agent to the tissue(s).
  • In an aspect of this embodiment the bioactive agent is an adhesive comprising the layer in contact with the tissue(s). The method further comprises setting the adhesive to join the tissues. In a related aspect the adhesive may be contained within a rupturable reservoir. The method further comprises rupturing the reservoir prior to setting the adhesive.
  • In another aspect of this embodiment the bioactive agent is a pharmaceutical comprising one or more of the layers disposed in protective relationship with a porous or permeable adhesive in contact with the tissue(s). The method further comprises diffusing the pharmaceutical from the layer(s) through the porous or permeable adhesive layer. In a related aspect the pharmaceutical may be contained within a rupturable reservoir. The method further comprises rupturing the reservoir prior to diffusing the adhesive. In all aspects of this embodiment the laminate device and the adhesive are as described supra.
  • In still another embodiment of the present invention, there is provided a dispenser for an adhesive tape, comprising a biocompatible non-adherent substance; a means to dispense an adhesive layer onto a layer of the biocompatible non-adherent substance; a means to cut the combined layers; and a housing having an opening. The biocompatible non-adherent substance, the layer thereof and the additional agents added thereto and the adhesive are as described supra.
  • In one aspect of this embodiment the means to dispense the adhesive comprises a brush impregnated with the adhesive. In a related aspect the means to dispense the adhesive comprises a brush and an ampoule to contain the adhesive fluidly connected to the brush.
  • In still another embodiment of the present invention, there is provided a method of forming an adhesive tape to join one or more tissues, comprising withdrawing a length of the layer of the biocompatible non-adherent substance through the opening in the dispensor described supra; simultaneously dispensing the adhesive layer along the length of the layer of the biocompatible non-adherent substance via the brush in the dispensor and cutting the combined layers via the cutting means comprising the dispenser after sufficient length has been withdrawn thereby forming the adhesive tape. Further to this embodiment the method provides for positioning the adhesive tape on one or more tissues such that the adhesive layer is in contact with the tissue(s) and setting the adhesive thereby joining the tissue(s).
  • Provided herein are protective adherent devices, patches or adhesive tapes to join and aid the joining of biological tissues by adhesion. The patch or tape includes a fast-setting adhesive or other type of tissue adhesive and a shield or laminate(s) that are at least in part comprised of a protective layer(s) that preferentially dissolve upon exposure to body fluids or water. Additional layers of the patch may include pharmaceuticals or other biologics. Also provided is a device to dispense the tape comprising a biocompatible laminate and fast-setting adhesive. The protective patches or tapes and dispensors may be used for closing a wound following trauma or a surgical procedure.
  • A tissue patch may comprise a protective layer of a laminate or shield comprising a non-adherent biocompatible material placed in contact with a fast-setting adhesive layer. The adhesive is, preferably, a cyanoacrylate, or is derived from the cyanoacrylates, but also may include other synthetic and naturally-occurring adhesives used in tissues. Included are protein adhesives, e.g. fibrin, collagen, and activated adhesives, such as those used in laser tissue welding.
  • Optionally, the non-adherent biocompatible material may dissolve in water. The biocompatible material may be a hydrocolloid material and may comprise a carbohydrate, such as pullulan. The biocompatible material comprising the shield or laminate may be, inter alia, poly(DL-lactic-co-glycolic acid), whey-protein emulsion with sorbitol, glycerol with butterfat and candelilla wax, arabinoxylans and hydrogenated palm kernel oil, calcium caseinate and whey protein, carboxymethylcellulose, pectin, milk-protein, or resins. Alternatively, the biocompatible material may be coated with a non-stick material, such as, but not limited to, a lipid, on the surface that comes into contact with the adhesive and so can be immediately removed from the adhesive upon polymerization of the latter.
  • A non-dissolving biocompatible laminate or shield may be placed in contact with a fast-setting adhesive to form a tape. The non-dissolving biocompatible laminate is textured with a plurality of projections to aid in wound closure. The projections provide means to manually draw apposed tissue toward the dissection line without necessity of forceps.
  • Additionally, the laminate tissue patch may comprise a non-stick removable layer to prevent inadvertent adhesion to the adhesive. The non-stick removable layer may be positioned in contact with the dissolvable biocompatible laminate which is in contact with the fast-setting adhesive layer to form a tissue tape. Alternatively, the laminate tissue patch may comprise a dissolvable biocompatible material as an upper layer which is in contact with the fast-setting adhesive layer. The other side of the fast-setting adhesive is covered with the removable layer which prevents inadvertent sticking to the patch. The removable layer may be peeled away to expose the fast-setting adhesive prior to positioning the tissue patch on the individual.
  • The removable layer may comprise materials which do not stick to the fast-setting adhesive. For example, if the fast-setting adhesive is cyanoacrylate, the removable layer may comprise teflon or cellulose impregnated with a lipid, e.g. lecithin or wax. Representative lipids are lecithin or polyethylene glycol, and representative waxes are paraffin, beeswax, candelilla, carnauba, or ceresine.
  • The tissue patch may fasten at least two substrates in order to effect a bond between the substrates in an individual, in a plant or animal or in cells and tissues of other organisms. The patch is useful for approximating apposed edges of dissected tissue, for compromising infected tissue, for holding pharmaceuticals in place, or for occluding open wounds, iatrogenic or otherwise, for the purpose of minimizing the chance of infection. The biocompatible shield or laminate is intended to prevent the care-provider from inadvertently sticking him/herself to the adhesive material and yet will dissolve upon exposure to water without undesirable toxicity to the individual. Potentially corrosive, toxic, or otherwise undesirable material is shielded from contact with a human or inanimate applicator, thus allowing the applicator to manipulate the materials with greater freedom.
  • Generally, the protective layer or shield, either biocompatible or not, may comprise in part or in whole a hydrocolloid. Preferably, the hydrocolloid comprises a water soluble natural polysaccharide or derivatives, including pectin and derivatives, guar gum arabic, tragacanth gum, xanthan gum, gellan sodium salt, propyleneglycol alginate, starches (amylose, amylopectin), modified starches, hydroxyethyl starch, pullulan, carboxymethyl starch, gum ghatti, okra gum, karaya gum, dextrans, dextrins and maltodextrins, konjac, acemannan from aloe, locust bean gum, tara gum, quince seed gum, fenugreek seed gum, scleroglucan, gum arabic, psyllium seed gum, tamarind gum, oat gum, quince seed gum, carrageenans, scleraglucan, succinoglucan, larch arabinogalactan, flaxseed gum, chondroitin sulfates, hyaluronic acid, curdlan, chitosan, deacetylated konjac, and rhizobium gum.
  • The hydrocolloid may be a water soluble non-gelling polypeptide or protein exemplified by gelatins, albumins, milk proteins, soy protein, and whey proteins. The hydrocolloid further may be selected from a group of synthetic hydrocolloids exemplified by polyethyleneimine, hydroxyethyl cellulose, sodium carboxymethyl cellulose, carboxymethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methyl cellulose, methyl cellulose, ethyl cellulose, polyacrylic acids, low molecular weight polyacrylamides and their sodium salts (carbomers), polyvinylpyrollidone, polyethylene glycols, polyethylene oxides, polyvinyl alcohols, pluronics, tetronics, and other block co-polymers, carboxyvinyl polymers, and colloidal silicon dioxide.
  • Suitable hydrocolloids or mixtures producing synergistic properties comprise natural seaweeds, natural seed gums, natural plant exudates, natural fruit extracts, biosynthetic gums, gelatines, biosynthetic processed starch or cellulosic materials, alginates, agar gum, guar gum, locust bean gum (carob), carrageenan, tara gum, gum arabic, ghatti gum, Khaya grandifolia gum, tragacanth gum, karaya gum, pectin, arabian (araban), xanthan, gellan, starch, Konjac mannan, galactomannan, funoran, are xanthan, acetan, gellan, welan, rhamsan, furcelleran, succinoglycan, scleroglycan, schizophyllan, tamarind gum, curdlan, pullulan, and dextran
  • Additionally, the biocompatible laminate or shield may comprise any or all of emulsifying agents, solubilizing agents, wetting agents, taste modifying agents, plasticizers, active agents, water soluble inert fillers, preservatives, buffering agents, coloring agents, and stabilizers. Addition of a plasticizer to the formulation can improve flexibility. The plasticizer or mixture of plasticizers may be polyethylene glycol, glycerol, sorbitol, sucrose, corn syrup, fructose, dioctylsodiumsulfosuccinate, triethylcitrate, tributylcitrate, 1,2-propylenglycol, mono-, di- or triacetates of glycerol, or natural gums. Preferred plasticizers are glycerol, polyethylene glycol, propylene glycol, citrates and their combinations. The amount of plasticizer depends on the final application.
  • Examples of natural water-soluble polymers include plant-type polymers, microorganism-type polymers and animal-type polymers. A plant-type polymer may be gum arabic, gum tragacanth, galactan, guar gum, carob gum, karaya gum, carrageenan, pectin, agar, quince seed or Cydonia oblonga, algae colloids such as brown algae extract, starches such as rice, corn, potato, and wheat, and glycyrrhizic acid. Microorganism-type polymers may be xanthan gum, dextran, succinoglucan, and pullulan. Animal-type polymers may be collagen, casein, albumin, and gelatin.
  • Examples of the semisynthetic water-soluble polymers include starch-type polymers, cellulosic polymers and alginic acid-type polymers. Starch-type polymers may be carboxymethyl starch and methylhydroxypropyl starch. Cellulosic polymers may be methyl cellulose, ethyl cellulose, methylhydroxypropyl cellulose, hydroxyethyl cellulose, cellulose sodium sulfate, hydroxypropyl cellulose, carboxymetyl-cellulose, sodium carboxymethyl cellulose, crystal cellulose, and cellulose powder. Alginic acid-type polymers may be sodium alginate and\ propyleneglycol-alginate.
  • Examples of the synthetic water-soluble polymers include vinyl polymers, polyoxyethylene-type polymers, acrylic polymers, and cationic polymers, and polyethyleneimine. Vinyl polymers may be polyvinyl alcohol, polyvinyl methyl ether, polyvinylpyrrolidone, carboxy vinyl polymer. Polyoxyethylene-type polymers may be a copolymer of polyethylene glycol 20,000, 40,000, or 60,000 and polyoxyethylene polyoxypropylene. Acrylic polymers may be sodium polyacrylate, polyethylacrylate, and polyacrylamide.
  • Thickeners may include gum arabic, carrageenan, karaya gum, gum tragacanth, carob gum, quince seed or Cydonia oblonga, casein, dextrin, gelatin, sodium pectate, sodium alginate, methyl cellulose, ethyl cellulose, CMC, hydroxy ethyl cellulose, hydroxypropyl cellulose, PVA, PVM, PVP, sodium polyacrylate, carboxy vinyl polymer, locust bean gum, guar gum, tamarind gum, cellulose dialkyl dimethylammonium sulfate, xanthan gum, aluminum magnesium silicate, bentonite, hectorite, AIMg silicate or beagum, laponite, and silicic acid anhydride.
  • Additionally, the present invention provides a shield or laminate for an adhesive or an adhesive laminate whereby an external layer of the shield may dissolve upon contact with fluids. The soluble, external shield may serve as an applicator to facilitate the application of the adhesive to tissue. The shield or laminate also may comprise one or more internal layers, reservoirs or pooled materials containing the adhesive. Furthermore multiple layers or reservoirs may contain a biologic, a drug or other pharmaceutical substance, whereby the system becomes a drug delivery device. The bioactive material may be, although not limited to, one of or a combination of nitroglycerin, an anti-nauseant, an antibiotic, a hormone, a steroidal anti-inflammatory agent, a non-steroid antiinflammatory agent, a chemotherapeutic agent, an anti-cancer agent, an immunogen, an analgesic, an anti-viral agent or an anti-fungal agent.
  • The layers used as a barrier to separate the adhesive from the backing, or the adhesive from the substrate, may be removed upon application. Alternatively, a layer may be designed to allow for release of the active agent, e.g., adhesive or biologic, drug or other pharmaceutical substance, upon activation, whereby the activation consists of compromising the layer. Examples include perforation, or dissolution upon exposure to fluids or heat, e.g.
  • body heat, thus allowing the active agent to flow past the barrier. Alternatively, the adhesive layer may be separate from the barrier layer and may be porous or permeable whereby, upon mechanically compromising the integrity of a reservoir contained within the barrier layer or laminate, a bioactive material, such as a pharmaceutical, is released to diffuse through the adhesive layer.
  • The present invention provides dispensers for the laminates and adhesives described herein. The dispenser may hold the laminate, a portion of which is withdrawn from the dispenser as needed. The fast-setting adhesive is applied to a side of the laminate whereupon the dispenser is used to cut the laminate. This provides an adhesive tape used to effect a bond between the substrates in an individual. Alternatively, a dispenser may dispense a fast-setting adhesive contiguous with the laminate. When the adhesive dispenser is mechanically disrupted, the adhesive flows into the laminate.
  • As described below, the invention provides a number of therapeutic advantages and uses, however such advantages and uses are not limited by such description. Embodiments of the present invention are better illustrated with reference to the FIGS. 1-5, however, such reference is not meant to limit the present invention in any fashion. The embodiments and variations described in detail herein are to be interpreted by the appended claims and equivalents thereof.
  • FIGS. 1A-1C depict examples of adherent tissue patches. In FIG. 1A the tissue patch 12 comprises a protective layer 14, which is a non-adherent biocompatible material and optionally water soluble, the inferior surface of which is disposed on and in contact with the superior surface of a fast-setting adhesive layer 16, such as cyanoacrylate. Alternatively, the biocompatible material 14 may be coated with a non-stick material (not shown), such as a lipid, on the inferior surface that comes into contact with the adhesive 16, and so can be immediately removed from the adhesive 16 upon polymerization of the latter.
  • FIG. 1B depicts a tissue patch 12 comprising a biocompatible material 14, the inferior surface of which is disposed on and in contact with the superior surface of a fast-setting adhesive layer 16. The superior surface of the biocompatible material 14 is disposed on and in contact with the inferior surface of a covering material 18 that allows the care provider to apply downward force to the patch 12 and not contaminate the biocompatible material 14. The covering material 18 may be peeled away from the biocompatible material 14 after application of the patch 12 to the tissue (not shown).
  • Alternatively, in FIG. 1C, a patch 12 comprises a biocompatible material 14, the inferior surface of which is disposed on and in contact with the superior surface of a fast-setting adhesive layer 16. The inferior side of the fast-setting adhesive 16 is in contact with and covered by a removable layer 20 intended to prevent inadvertent sticking to the patch 12. Peeling away the removable layer 20 at position 22 exposes the fast-setting adhesive 14 prior to positioning the patch 12 on the individual. The removable layer 20 may comprise materials which do not stick to the fast-setting adhesive 14.
  • With continued reference to FIG. 1A, FIG. 2 depicts a laminate adhesive patch 12, which has a shape that allows application to the substrates, e.g., a hand 50 with wound 55, in a way that the apposed edges 52,54 of the wound 50 may be drawn together without the use of forceps or without inadvertent adhesion of the care-provider to the patch 12. A first part 32 of the patch 12 may be applied to the side of the wound 50 having wound edge 52. A second part 34 of the patch 12 may be applied to the side of the wound 50 having wound edge 54 to maintain close contact between the apposed wound edges 52,54. The patch 12 further comprises an additional plurality of parts 36 joining the first and second parts 32,34 of the patch 12 which maintain tension across the wound 50 thus minimizing dihescence. Optionally, parts 36 may shrink with the application of heat
  • Still with continued reference to FIG. 1A, FIG. 3A depicts a laminate adhesive patch 12 comprising a biocompatible material 14, which has an internal reservoir 60 containing bioactive material 70, the inferior surface of which is disposed on and in contact with the superior surface of a porous biocompatible adhesive layer 62 comprising a fast-setting adhesive 64 and perforations 66 between the superior and inferior surfaces of the porous biocompatible layer 62. Upon mechanically compromising the integrity of the reservoir 60, the bioactive material 70 diffuses through the porous layer 62 and is beneficially delivered to the tissue (not shown) on which the patch 12 is applied.
  • FIG. 3B depicts a laminate adhesive patch 12 comprising a biocompatible material 14, which has an internal reservoir 60 containing bioactive material 70, the inferior surface of which is disposed on and in contact with the superior surface of a permeable biocompatible adhesive layer 68 comprising a fast-setting adhesive 64. The adhesive layer 68 is of such a composition that the bioactive material 70 can permeate through. The remainder of the patch 12 dissolves upon being exposed to water. The bioactive material 70 can be a pharmaceutical.
  • Again with continued reference to FIG. 1A, FIG. 4 depicts a dispenser 80 comprising a roll 82 of biocompatible material 14 which can be drawn, through manual effort, from the dispenser 80. When the biocompatible material 14 is drawn from the dispenser 80, it contacts brush 84, or other applicator, which is impregnated with the fast-acting adhesive 16. The adhesive 16 coats the biocompatible material 14 as it contacts brush 84, thus forming an adhesive tape 90. A cutter 86 cuts adhesive tape 90 when an appropriate length has been drawn through the dispenser 80.
  • Optionally, the dispenser 80 may comprise a receptacle 88 to contain the fast-acting adhesive 16 which may polymerize rapidly upon contact with air and/or moisture. Recepticle 88 may be broken open manually, for example, as with a glass ampoule, prior to use of the dispensor 80. Upon breaking the recepticle 88, the adhesive 16 flows into the brush 84. The brush 84 is impregnated with adhesive 16 and can apply the adhesive 16 to the biocompatible material 14.
  • The following examples are given for the purpose of illustrating various embodiments of the invention and are not meant to limit the present invention in any fashion.
  • EXAMPLE 1 Inhibition of Cyanoacrylate Polymerization
  • A drop of commercial industrial fast-drying cyanoacrylate adhesive was aliquoted onto a small piece of Parafilm-M (Pechiney Plastic Packaging, Chicago Ill.) and onto a teflon cooking pan and left in ambient room conditions. In each case, the cyanoacrylate failed to polymerize. This result was unexpected as the cyanoacrylate is normally considered to combine with moisture in the air and thereby polymerize when in contact with virtually anything, as long as air is present.
  • EXAMPLE 2 Flexible Hot-Melt Adhesive
  • Several pieces of a gummi-type confectionary (Haribo Gummi-Bears) were slowly melted in a glass beaker at approximately 60° C. A sample of approximately 1 ml was placed on a standard glass microscope slide and another slide was then placed in contact with the molten material, overlapping the first slide by about 1 inch and left to dry overnight. The next day, it was impossible to manually separate the two microscope slides, although a small amount of movement was possible due to the elastic nature of the adhesive.
  • EXAMPLE 3 Hot-Melt Adhesive Sticks to PTFE
  • Approximately 20 g of Haribo Gummi-Bears was slowly melted in a glass beaker at approximately 60° C. A mixture of 75% ovalbumin in water was stirred into the confectionary while it was still molten. Samples of the still molten adhesive was placed on teflon (PTFE) cooking pans and pressed down with a teflon plate weighing 1 kg. In one case, a thin film of mineral oil was spread over the PTFE plate prior to application of the adhesive. In another case, a small amount of plastisizer (5% pullulan) was added to the molten mixture prior to application on the PTFE plate.
  • After allowing to cure overnight, the 1 kg teflon plates were removed and an attempt was made to manually remove the adhesive from the underneath PTFE cooking pan. In all cases, the adhesive adhered very strongly to the plate, which is surprising as only a few materials are known to adhere to teflon. The adhesive with plastisizer stuck best and couldn't be removed, while the adhesive without plastisizer would only be removed by scraping it off with a spatula-like device.
  • EXAMPLE 4
  • Ablation of Stratum Corneum with Cyanoacrylate
  • A drop of commercial industrial fast-drying cyanoacrylate (Krazy Glue) was aliquoted onto a small piece of clear acetate film. The film was then inverted and placed on the dorsum of a volunteer's forearm. After a period of 2 minutes, a corner of the acetate was raised and the entire piece was rapidly removed from the skin. It was apparent that at least part of the stratum corneum was removed and was left on the acetate sheet, along with any hair that was present on the skin at the treatment site. Application to the ablation site of 200 microliters of 1% lidocaine with epinephrine for 5 minutes and subsequent probing of the site with a 25G hypodermic needle gave evidence of some degree of anesthesia. The epinephrine caused a blanching of the skin, as measured by a Minolta chromameter. These results are clear evidence of stratum corneum ablation with the cyanoacrylate and film laminate.
  • EXAMPLE 5 Biocompatible Films
  • Several different formulations of thin films were tested for various desirable mechanical properties such as thickness, strength, elasticity and water-solubility: (1) 11% aqueous solution of pullulan; (2) 6% aqueous solution of pullulan with 2.5% aqueous gelatin; (3) 3% aqueous solution of pullulan with approximately 11% glycerol and 3.8% PEG8000 (polyethylene glycerol with a molecular weight of 8000) added; and (4) 6% aqueous solution of pullulan with 0.3% aqueous iota-carageenen. Aliquots of the four test films were applied to a PTFE cooking plate and left to dry overnight. All of the dried samples varied between 0.06 and 0.15 mm in thickness.
  • Sample 1 was smooth and quite strong, while sample 2 had undesirable bubbles and was more fragile. Sample 3 was strong and much more flexible than sample 1, while sample 4 was also flexible, but not as smooth as the other samples. None of the samples adhered strongly to the PTFE plate. One film with excellent properties as a laminate film was made out of water, pullulan, PEG8000, and glycerol. Other concentrations of these four components were tested which provided superior flexibility, elasticity and uniformity in thickness. Other potentially useful films were made up of pullan (e.g. 5%) and iota-carageenen (e.g. 0.38%). All samples subsequently dissolved well in water, although at differing rates.
  • EXAMPLE 6 More Biocompatible Films
  • Several more formulations of thin films were tested for various desirable mechanical properties: (1) 10% aqueous lambda carageenen-results after drying overnight: elastic, flexible and with high tensile strength; (2) 0.75% aqueous lambda carageenen with 25% glycerol-results after drying overnight: sticks well to PTFE plate, but not to fingers; (3) 0.5% aqueous lambda carageenen with 0.5% PEG8000-results after drying overnight: very uniform, strong and flexible, but slightly retarded dissolving time in water; (4) 5% aqueous pullulan and 0.5% lambda carageenen-results after drying overnight: strong and flexible, but not very elastic, good solubility in water, adheres to moist tissue readily); (5) 10% aqueous hydroxypropyl cellulose-results after drying overnight: very strong and flexible, slightly elastic, vinyl-like; (6) 0.86% aqueous lambda carageenen and 14% glycerol-results after drying overnight: elastic, doesn't adhere to dry tissue readily but adheres readily to moist tissue; (6) 2.5% aqueous hydroxypropyl cellulose, 5% lambda carageenen and 2.5% pullulan-results after drying overnight: strong and flexible, slightly elastic, good solubility in water.
  • EXAMPLE 7 Thin Film Adhesive Shields
  • Several thin films were prepared for the purpose of shielding adhesives. Cyanoacrylate glues were applied to human skin or to wood strips, then covered with thin films prepared from formulations comprised primarily of pullulan and lambda-carageenan. Polysorbate-A was added in low concentrations in some formulations. Thin films were prepared by mixing pullulan (5-10% w/v), lambda-carageen (0.1-0.5% w/v) and polysorbate-A (0-0.1% v/v). In some samples food coloring was added to improve visibility.
  • Samples (15 ml) were applied to the center of 7 cm diameter plastic rings and the material was allowed to dry overnight, resulting in thin films (approx. 20-50 micron thickness) with good flexibility and solubility characteristics. Upon further evaluation, it was demonstrated that the shields could be applied to the surface of cyanoacrylate glues, as well as other adhesives, and then washed from the surface following curing of the glue, with no apparent alteration of the glue.
  • EXAMPLE 8 Thin Film Adhesive Laminates
  • Multi-layer laminates were prepared for the purpose of shielding adhesives and improving the adherence of the laminate to tissues. In this experiment, the adhesive shield was prepared as in Examples 5-7. Various films then were applied to one another prior to complete drying. In these experiments, films prepared as described in Examples 5 and 6 were allowed to reach 75-95% dryness before layering with the shield material prepared as in example 7. This resulted in laminates with different properties on each side.
  • The adhesive shield on one side allowed the material to be manipulated freely, while the other side provided for other properties, such as tissue adherence. At times, adhesives were sandwiched between the two films in order to provide a complete system. With this type of laminate, an adhesive material may be applied to the surface of moist membranous wounds, such that the tissue adhering layer immediately sticks to the tissue, thereby immediately localizing the adhesive at the wound site, while a protective layer shields the applicator from the adhesive
  • One skilled in the art will appreciate readily that the present invention is well adapted to carry out the objects and obtain the ends and advantages mentioned, as well as those objects, ends and advantages inherent herein. The present examples, along with the methods, procedures, treatments, molecules, and specific compounds described herein are presently representative of preferred embodiments, are exemplary, and are not intended as limitations on the scope of the invention. Changes therein and other uses will occur to those skilled in the art which are encompassed within the spirit of the invention as defined by the scope of the claims.

Claims (9)

What is claimed is:
1. A dispenser for an adhesive tape, comprising:
a biocompatible non-adherent substance;
a means to dispense an adhesive layer onto a layer of said biocompatible non-adherent substance;
a means to cut said combined layers; and
a housing having an opening.
2. The dispenser of claim 1, wherein said biocompatible non-adherent substance dissolves upon contact with a fluid.
3. The dispenser of claim 1, wherein one or more layers of said biocompatible non-adherent substance comprises a hydrocolloid.
4. The dispenser of claim 1, wherein the layer of said biocompatible non-adherent substance further comprises an emulsifying agent, a solubilizing agent, a wetting agent, a taste modifying agent, a plasticizer, a bioactive agent, a water soluble inert filler, a preservative, a buffering agent, a coloring agent, a stabilizer, or a combination thereof.
5. The dispenser of claim 1, wherein said adhesive is cyanoacrylate or a derivative thereof, a protein or a synthetic polymer.
6. The dispenser of claim 1, wherein the means to dispense said adhesive comprises a brush impregnated with said adhesive.
7. The dispenser of claim 1, wherein the means to dispense said adhesive comprises:
a brush; and
an ampoule to contain said adhesive fluidly connected to said brush.
8. A method of forming an adhesive tape to join one or more tissues, comprising:
withdrawing a length of the layer of said biocompatible non-adherent substance through the opening in the dispensor of claim 1;
simultaneously dispensing the adhesive layer along the length of the layer of said biocompatible non-adherent substance via the brush in said dispensor; and
cutting the combined layers via the cutting means comprising said dispenser after sufficient length has been withdrawn thereby forming said adhesive tape.
9. The method of claim 8, further comprising:
positioning said adhesive tape on one or more tissues, said adhesive layer in contact with said tissue(s); and
setting said adhesive thereby joining said tissue(s).
US13/300,177 2004-01-08 2011-11-18 Adhesive Laminates for Rapid Wound Occlusion Abandoned US20120065672A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US53491704P true 2004-01-08 2004-01-08
US11/032,427 US7758939B2 (en) 2004-01-08 2005-01-10 Adhesive laminates for rapid wound occlusion
US12/804,292 US8053052B2 (en) 2004-01-08 2010-07-19 Adhesive laminates for rapid wound occlusion
US13/291,619 US8343606B2 (en) 2004-01-08 2011-11-08 Adhesive laminates for rapid wound occlusion
US13/300,177 US20120065672A1 (en) 2004-01-08 2011-11-18 Adhesive Laminates for Rapid Wound Occlusion

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13/300,177 US20120065672A1 (en) 2004-01-08 2011-11-18 Adhesive Laminates for Rapid Wound Occlusion

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US13/291,619 Division US8343606B2 (en) 2004-01-08 2011-11-08 Adhesive laminates for rapid wound occlusion

Publications (1)

Publication Number Publication Date
US20120065672A1 true US20120065672A1 (en) 2012-03-15

Family

ID=34806889

Family Applications (4)

Application Number Title Priority Date Filing Date
US11/032,427 Expired - Fee Related US7758939B2 (en) 2004-01-08 2005-01-10 Adhesive laminates for rapid wound occlusion
US12/804,292 Expired - Fee Related US8053052B2 (en) 2004-01-08 2010-07-19 Adhesive laminates for rapid wound occlusion
US13/291,619 Expired - Fee Related US8343606B2 (en) 2004-01-08 2011-11-08 Adhesive laminates for rapid wound occlusion
US13/300,177 Abandoned US20120065672A1 (en) 2004-01-08 2011-11-18 Adhesive Laminates for Rapid Wound Occlusion

Family Applications Before (3)

Application Number Title Priority Date Filing Date
US11/032,427 Expired - Fee Related US7758939B2 (en) 2004-01-08 2005-01-10 Adhesive laminates for rapid wound occlusion
US12/804,292 Expired - Fee Related US8053052B2 (en) 2004-01-08 2010-07-19 Adhesive laminates for rapid wound occlusion
US13/291,619 Expired - Fee Related US8343606B2 (en) 2004-01-08 2011-11-08 Adhesive laminates for rapid wound occlusion

Country Status (3)

Country Link
US (4) US7758939B2 (en)
EP (1) EP1713404A4 (en)
WO (1) WO2005070105A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106108966A (en) * 2016-08-22 2016-11-16 湖南豌豆医疗投资有限公司 A noninvasive skin wound stapler

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050182443A1 (en) * 2004-02-18 2005-08-18 Closure Medical Corporation Adhesive-containing wound closure device and method
US20070185229A1 (en) * 2006-02-08 2007-08-09 Bristol-Myers Squibb Company Formulation for improving skin adhesive effectiveness
US20090099579A1 (en) 2007-10-16 2009-04-16 Tyco Healthcare Group Lp Self-adherent implants and methods of preparation
AU2009220147A1 (en) * 2008-03-07 2009-09-11 Lectec Corporation Hand sanitizing patch
WO2009141591A1 (en) * 2008-05-19 2009-11-26 Jean-Pierre Lilley Varicose vein treatment
US9060926B2 (en) 2008-10-31 2015-06-23 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US8731841B2 (en) 2008-10-31 2014-05-20 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US9050317B2 (en) 2008-10-31 2015-06-09 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US9072688B2 (en) 2008-10-31 2015-07-07 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US8409376B2 (en) 2008-10-31 2013-04-02 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US8721583B2 (en) 2008-10-31 2014-05-13 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US9050070B2 (en) 2008-10-31 2015-06-09 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US8793075B2 (en) 2008-10-31 2014-07-29 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US8551505B2 (en) 2008-10-31 2013-10-08 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US20100111857A1 (en) 2008-10-31 2010-05-06 Boyden Edward S Compositions and methods for surface abrasion with frozen particles
US8788211B2 (en) 2008-10-31 2014-07-22 The Invention Science Fund I, Llc Method and system for comparing tissue ablation or abrasion data to data related to administration of a frozen particle composition
US8762067B2 (en) 2008-10-31 2014-06-24 The Invention Science Fund I, Llc Methods and systems for ablation or abrasion with frozen particles and comparing tissue surface ablation or abrasion data to clinical outcome data
US8725420B2 (en) 2008-10-31 2014-05-13 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US8731840B2 (en) 2008-10-31 2014-05-20 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US8545855B2 (en) 2008-10-31 2013-10-01 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US9060934B2 (en) 2008-10-31 2015-06-23 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US9072799B2 (en) 2008-10-31 2015-07-07 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US10159825B2 (en) 2009-09-17 2018-12-25 Zipline Medical, Inc. Rapid closing surgical closure device
US10123801B2 (en) 2011-11-01 2018-11-13 Zipline Medical, Inc. Means to prevent wound dressings from adhering to closure device
WO2011043786A1 (en) 2009-09-17 2011-04-14 Zipline Medical, Inc. Rapid closing surgical closure device
US20120157763A1 (en) * 2010-12-16 2012-06-21 Ryan Darnell Method and apparatus for reducing tissue trauma during ipp procedure
US9132194B2 (en) * 2011-07-12 2015-09-15 Warsaw Orthopedic, Inc. Medical devices and methods comprising an adhesive sheet containing a drug depot
US8672957B2 (en) 2011-07-28 2014-03-18 Sealantis Ltd. Adhesive patch vascular applicator
US9561034B2 (en) 2011-11-01 2017-02-07 Zipline Medical, Inc. Surgical incision and closure apparatus
US9050086B2 (en) * 2011-11-01 2015-06-09 Zipline Medical, Inc. Surgical incision and closure apparatus
US10123800B2 (en) 2011-11-01 2018-11-13 Zipline Medical, Inc. Surgical incision and closure apparatus with integrated force distribution
US9572580B2 (en) * 2012-03-16 2017-02-21 Covidien Lp Closure tape dispenser
US9161756B2 (en) 2012-03-16 2015-10-20 Covidien Lp Closure tape dispenser
US9949738B2 (en) 2013-07-12 2018-04-24 Vasoinnovations, Inc. Method to stop bleeding, with short hemostasis duration using a low dose of anticoagulant
US10213214B2 (en) 2013-07-12 2019-02-26 Vasoinnovations, Inc. Method to stop bleeding, with short hemostasis duration using a low dose of anticoagulant
US9332994B2 (en) 2013-07-12 2016-05-10 Vasoinnovations, Inc. Apparatus and method to stop bleeding
US9668744B2 (en) 2015-08-05 2017-06-06 Vasoinnovations, Inc. Apparatus and method to stop bleeding
US9308000B2 (en) 2013-07-12 2016-04-12 Vasoinnovations, Inc. Method of transradial catheterization, device for ulnar artery compression, and method of use
AU2016203461B1 (en) * 2015-08-05 2016-11-03 Samir Bipin PANCHOLY Apparatus and method to stop bleeding
CA2993297A1 (en) * 2015-08-05 2017-02-09 Vasoinnovations, Inc. Apparatus and method to stop bleeding
US20180000495A1 (en) 2013-07-12 2018-01-04 Vasoinnovations, Inc. Method to stop bleeding, with short hemostasis duration using a low dose of anticoagulant
KR20160106630A (en) * 2014-01-05 2016-09-12 집라인 메디칼, 인크. Instrumented wound closure device
USD824525S1 (en) 2014-09-25 2018-07-31 Ethicon Llc Release paper for wound treament devices

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020148556A1 (en) * 2000-05-02 2002-10-17 Toshikazu Kawada Labeling method and hand labeler therefor
US20030080151A1 (en) * 1998-10-22 2003-05-01 Closure Medical Corporation Applicator with protective barrier

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4427737A (en) * 1981-04-23 1984-01-24 E. R. Squibb & Sons, Inc. Microporous adhesive tape
US4447482A (en) * 1982-01-21 1984-05-08 Shur Medical Corporation Wound closure tape and applicator therefor
US4538603A (en) * 1982-04-22 1985-09-03 E. R. Squibb & Sons, Inc. Dressings, granules, and their use in treating wounds
WO1991001688A1 (en) * 1989-08-02 1991-02-21 Pierre Nahon Adhesive skin suture device
US5681579A (en) * 1993-03-22 1997-10-28 E.R. Squibb & Sons, Inc. Polymeric support wound dressing
CA2169729C (en) * 1993-08-19 2001-04-03 James E. Biegajski Water-soluble pressure-sensitive mucoadhesive
WO1995031223A1 (en) * 1994-05-13 1995-11-23 Kuraray Co., Ltd. Medical polymer gel
CA2317066A1 (en) * 1997-10-03 1999-04-15 Lavipharm Laboratories, Inc. A prolamine-plant polar lipid composition, its method of preparation and applications thereof
US6183770B1 (en) * 1999-04-15 2001-02-06 Acutek International Carrier patch for the delivery of agents to the skin
US6632450B1 (en) * 2000-05-16 2003-10-14 Kenton Gregory Adherable biomaterial patches and methods for producing and for using same
US6296607B1 (en) * 2000-10-20 2001-10-02 Praxis, Llc. In situ bulking device
US20030044380A1 (en) * 2001-07-19 2003-03-06 Zhu Yong Hua Adhesive including medicament

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030080151A1 (en) * 1998-10-22 2003-05-01 Closure Medical Corporation Applicator with protective barrier
US20020148556A1 (en) * 2000-05-02 2002-10-17 Toshikazu Kawada Labeling method and hand labeler therefor

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106108966A (en) * 2016-08-22 2016-11-16 湖南豌豆医疗投资有限公司 A noninvasive skin wound stapler

Also Published As

Publication number Publication date
US20100291187A1 (en) 2010-11-18
US20120052111A1 (en) 2012-03-01
WO2005070105A2 (en) 2005-08-04
US8053052B2 (en) 2011-11-08
WO2005070105A3 (en) 2006-12-07
US20050153090A1 (en) 2005-07-14
EP1713404A2 (en) 2006-10-25
EP1713404A4 (en) 2009-07-29
US8343606B2 (en) 2013-01-01
US7758939B2 (en) 2010-07-20

Similar Documents

Publication Publication Date Title
JP3810447B2 (en) Wound dressing
US5989215A (en) Fibrin delivery device and method for forming fibrin on a surface
US5201704A (en) Method of making and using a hemostatic agent applicator
JP2604542B2 (en) The wound dressing product
EP0494855B1 (en) Hydrogel-forming wound dressing or skin coating material
JP5965572B2 (en) Solid dressing for treating wounded tissue
US5013769A (en) Method of making a hydrogel-forming wound dressing or skin coating material
AU2005244214B2 (en) Topical methadone compositions and methods for using the same
JP6293071B2 (en) Instrument for closing vascular puncture
JP5038576B2 (en) Patch
CA2424579C (en) Ultraviolet-screening patch
CN1118302C (en) Adhesive agent and producing method thereof
US9655622B2 (en) Adhesive-containing wound closure device and method
US6992233B2 (en) Material delivery system
EP2424948B1 (en) Releasable adhesive having a multilayer substrate
US6231872B1 (en) Structured occlusive dressings
EP1401352B1 (en) Method for producing a chitosan wound dressing
US7122712B2 (en) Surgical bandage and methods for treating open wounds
EP1691748B1 (en) A dressing product
ES2180536T5 (en) Management system based on the solubility parameter and method for altering the saturation concentration of the drug drug.
EP1181930A1 (en) Patch
EP1731175A1 (en) Hemostatic polymer useful for rapid blood coagulation and hemostatis
US5513635A (en) Nasal cannula anchoring apparatus
US20020169476A1 (en) Method for hemostasis
US6348212B2 (en) Treating traumatic burns or blisters of the skin

Legal Events

Date Code Title Description
AS Assignment

Owner name: ROCKY MOUNTAIN BIOSYSTEMS, INC, COLORADO

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:FLOCK, STEPHEN;MARCHITTO, KEVIN;REEL/FRAME:033905/0127

Effective date: 20140930